UK markets closed

Medistim ASA (0OCD.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
174.00-44.02 (-20.19%)
At close: 05:43PM BST
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.76
52-week change 3-18.40%
S&P500 52-week change 322.64%
52-week high 3300.00
52-week low 3174.00
50-day moving average 3210.26
200-day moving average 3233.84

Share statistics

Avg vol (3-month) 398
Avg vol (10-day) 311
Shares outstanding 518.18M
Implied shares outstanding 6N/A
Float 815.49M
% held by insiders 125.40%
% held by institutions 157.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 34.50
Trailing annual dividend yield 32.06%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 19.92%
Operating margin (ttm)17.07%

Management effectiveness

Return on assets (ttm)16.62%
Return on equity (ttm)27.12%

Income statement

Revenue (ttm)521.11M
Revenue per share (ttm)28.53
Quarterly revenue growth (yoy)-4.20%
Gross profit (ttm)N/A
EBITDA 146.72M
Net income avi to common (ttm)103.82M
Diluted EPS (ttm)5.08
Quarterly earnings growth (yoy)-41.20%

Balance sheet

Total cash (mrq)153.87M
Total cash per share (mrq)8.42
Total debt (mrq)17.64M
Total debt/equity (mrq)4.43%
Current ratio (mrq)4.15
Book value per share (mrq)21.77

Cash flow statement

Operating cash flow (ttm)113.19M
Levered free cash flow (ttm)64.71M